ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease
Enrolling by invitation · Not applicable
Conditions studied: Thyroid Disease, Hashimoto's Thyroiditis, Hyperthyreosis and Goiter, Hypothyroidism
In brief
Objectives: This study aims to assess health-related quality of life (QoL) in adults with thyroid hormone disorders and identify modifiable factors to improve QoL in patients with Hashimoto's thyroiditis (HT) and multinodular toxic goiter (MNTG) through an exercise intervention. Primary Outcome: 1\. Assess the impact of a tailored exercise program on health-related QoL in patients with HT and MNTG using the ThyPRO questionnaire. Secondary Outcomes: 1. Evaluate the need for a screening tool to identify thyroid patients with reduced health-related QoL despite being euthyroid. 2. Assess the impact of the exercise intervention on body composition, strength, and balance function in HT and MNTG patients. Methods: The study is a combined cross-sectional survey and randomized controlled trial into the health related QoL in patients diagnosed with thyroid hormone disease. The cross-sectional survey will assess the overall health-related QoL in patients diagnosed with thyroid hormone disease, and help identify eligible participants for the subsequent RCT. The RCT will evaluate the efficacy of a comprehensive screening and exercise intervention in patients ≥ 65 years diagnosed with HT or MNTG, experiencing reduced health-related QoL. Participants: The aim is to recruit 74 patients with HT and 74 patients with MNTG, including 50 participants from each group with reduced health-related QoL (defined in this study as ThyPRO score ≥ 30) and 24 with good health-related QoL (ThyPRO score ≤ 20)
Key facts
- Study ID
- NCT06960005
- Run by
- Aalborg University Hospital
- People needed
- 148
- Starts
- 2026-05-15
- Expected to finish
- 2028-11-30
- Last updated by the study team
- 2026-04-17
Who can join
Age: 65 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women with minimum 65 years of age, with no upper limit.
- Verified diagnosis of HT or MNTG
- Euthyroid for at least 6 months
- Signed the informed consent
You may not qualify if…
- Current participation in a structured exercise program or regular physical exercise activity above 5 hours per week
- Previous experience with rhythm-based multitask exercise.
- Diagnosed with significant neurological diseases (e.g. Multiple Sclerosis and myasthenia gravis), vestibular diseases or newly orthopedic surgeries (e.g. knee or hip replacement)
- Fully dependent on walking aids
- Active malignancy or terminal illness
- Inability to understand Danish written and/or verbally
- Having severely impaired cognitive function, defined as a score below 8 on the cognitive assessment "the short orientation-memory-concentration test"
- Treatment with amiodarone within the last year
- No changes within the last six months in medications affecting weight or body composition - e.g., GLP-1 electrolyte/fluid balance - e.g., diuretics or corticosteroid
- Participation in other clinical intervention studies within the last six months
- For the cross sectional survey:
- Inclusion criteria:
- Men and women with a minimum of 18 years
- Diagnosis of primary hypothyroidism or primary hyperthyroidism
Where it is running
- Diabeteshuset — Gistrup, Denmark
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.